查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1466141

基因檢測市場：按產品類型、技術、應用、分銷管道、最終用戶分類 - 全球預測 2024-2030

Genetic Testing Market by Product (Consumables & Equipment, Software & Services), Test Type (Carrier Testing, Diagnostic Testing, New Born Screening), Technology, Application, Distribution Channel, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年基因檢測市場規模為118.9億美元，預計2024年將達135.5億美元，2030年將達297.9億美元，複合年成長率為14.01%。

基因檢測包括各種產品和服務，可分析個體的 DNA，以識別與遺傳特徵、疾病易感性和治療反應相關的特定基因、染色體和蛋白質。臨床診斷、藥物研發、生物技術創新、法醫學、營養基因體學和直接面對消費者的服務等各個領域都是該市場的重要業務領域。近年來，有幾個因素促成了基因檢測市場的顯著成長。 DNA測序技術（例如次世代定序(NGS)）的進步、人們對透過基因檢測進行早期診斷的益處的認知不斷提高、遺傳性疾病盛行率的增加、人口老齡化以及對個人化醫療的需求增加，消費者基因檢測服務的使用不斷增加。基因檢測市場的新成長機會包括與人工智慧（AI）、巨量資料分析和遠端醫療平台等其他最尖端科技的整合，進入亞太地區等高成長市場，以及加強官民合作關係組研究舉措。結果、應用針對個人遺傳特徵的精準醫療計劃，以及使用液態切片技術透過血液樣本中的循環腫瘤 DNA (ctDNA) 檢測早期癌症。然而，關於濫用遺傳資訊的隱私問題和倫理問題、公眾對基因檢測重要性缺乏認知、由於對某些人群進行高級檢測的成本高昂而造成的經濟限制，以及成長潛力受到一些限制和挑戰的阻礙包括不一致的指導方針和法規、對導致醫療保健專業人員和患者誤解的虛假結果的擔憂，以及認證遺傳諮詢師等領域的勞動力短缺。

主要市場統計
基準年[2023] 118.9億美元
預測年份 [2024] 135.5億美元
預測年份 [2030] 297.9億美元
複合年成長率（%） 14.01%

基因檢測市場的創新和研發是由CRISPR-Cas9等新型基因編輯技術的發展、生物資訊工具的增強以更好地解釋高通量測序平台生成的大量基因組資料以及無細胞基因組數據驅動的。應是探索使用胎兒DNA (cffDNA) 的非侵入性產前檢測(NIPT) 的新應用；透過藥物基因組學方法發現針對目標疾病狀態的獨特生物標記；擴展到環境基因組學等領域，以評估個體對各種環境的反應；因素。

產品：高效資料管理和分析的軟體和服務的普及

基因檢測產業的耗材和設備包括試劑、檢測套件、實驗室器具以及收集、處理和分析樣本所需的設備等產品。此欄位對於在各種應用中執行準確可靠的測試至關重要。診斷實驗室需要高品質的耗材，包括試劑和檢測試劑套件，以實現準確的疾病診斷。此外，研究機構需要定序儀和PCR裝置等先進設備來進行分子層面的基因研究。同時，軟體和服務包括用於資料儲存、管理和分析的生物資訊學工具，以及遺傳諮詢和諮詢服務。我們的軟體和服務專注於資料管理和分析解決方案，以滿足高效處理複雜基因組資料日益成長的需求。

測試類型：著重於診斷特定疾病的診斷測試。

基因帶原檢測是為了識別攜帶一份基因突變副本的個體的後代，這種基因突變與其他攜帶者配對時會導致遺傳疾病。通常會建議計劃生育的夫婦，尤其是有某些遺傳性疾病家族病史的夫婦。另一方面，診斷測試是在個體出現疾病症狀後或需要確認或排除特定診斷時進行的。新生兒篩檢測試有助於儘早發現新生兒潛在危及生命的感染疾病，並立即採取醫療干預措施。此測試通常涉及出生後立即抽血，也可能包括針對先天性心臟疾病的聽力測試和脈搏血氧計測試。藥物基因體學研究揭示了個體的基因組成如何影響藥物反應。了解這些差異可以幫助醫療保健專業人員最佳化藥物治療選擇和劑量，並改善治療結果。胚胎著床前診斷是對透過體外受精（IVF）獲得的胚胎進行，以在胚胎著床前識別先天性異常。胚胎著床前測試主要有兩種類型：胚胎著床前基因診斷（PGD），用於篩檢特定的遺傳疾病；以及胚胎著床前遺傳篩檢（PGS），用於評估胚胎的染色體組成。產前檢測有助於發現懷孕期間潛在的健康問題，包括診斷測試（例如羊膜穿刺術）和篩檢測試（例如非侵入性產前測試（NIPT））。無症狀性和預測測試可識別無症狀性人群的基因突變，這些人在以後的生活中患某種特定疾病的風險可能更高。這些檢測資訊使個人能夠就醫療保健策略做出明智的決定，並採取預防措施來降低疾病風險。

技術：更多地轉向 DNA序列測定，以實現準確的基因識別和疾病診斷

細胞遺傳學是對染色體異常及其在遺傳性疾病中的作用的研究。細胞遺傳學技術分析染色體的結構和數量，以識別可能與疾病發展有關的異常。常見的細胞遺傳學測試包括核型分析和螢光原位雜合反應（FISH）。 DNA序列測定技術可破解 DNA 分子內核苷酸的​​確切順序，識別基因並確定其功能。這項技術對於診斷遺傳疾病、檢測癌細胞內的基因突變以及指南個人化醫療方法有著很高的需求。基因表現同時測量數千個基因的活性水平，以了解基因在疾病發生和進展中的作用。基因表現技術可用於識別新的治療標靶、了解治療反應和指南個人化治療決策。微陣列和 RNA 定序 (RNA-seq) 是基因表現譜分析的常用技術。微陣列是用於分析基因表現和檢測單核苷酸多態性 (SNP) 等遺傳變異的高通量技術平台。選擇取決於您的需求，例如在基因組層面上研究基因功能或篩檢潛在的疾病相關生物標記。 PCR 是一種廣泛使用的分子生物學方法，用於擴增和定量特定 DNA 序列。 PCR 有多種應用，包括基因檢測、病原體檢測和法醫學分析。 PCR 的需求量很大，因為它可以用最少的樣品提供快速、準確的結果。

應用 擴大採用基因檢測來檢測癌症的早期跡象

自體免疫疾病是由免疫系統功能失調引起的，免疫系統會攻擊身體的細胞和組織。基因檢測對於確定這些疾病的遺傳傾向並實現早期檢測和有針對性的治療計劃至關重要。全面了解個人的遺傳傾向有助於檢測癌症的早期跡象並識別遺傳性風險，從而製定個人化的預防策略和標靶治療。心臟病、糖尿病和肥胖是環境因素和遺傳因素的複雜組合。基因檢測可以幫助確定個人對這些疾病的易感性，並制定量身定做的生活方式干涉措施和藥物治療方案以降低風險。囊腫纖維化、肌肉萎縮症和地中海貧血是由特定基因突變引起的。基因檢測可以準確診斷遺傳疾病，並且可以透過攜帶者篩檢來識別計劃生育的高風險夫妻。阿茲海默症、帕金森氏症和亨廷頓舞蹈症等神經退化性疾病可能與遺傳密切相關。基因檢測可以揭示這些疾病的易感性，並採取預防措施和早期療育來減緩疾病的進展。

銷售管道：基因檢測產品線上平台投放

線下分發包括醫院、診所和診斷實驗室等傳統實體場所，針對尋求醫療保健專業人員面對面個性化指導的個人。線下銷售的主要好處包括與醫療專業人員的直接諮詢、安全的樣本採集通訊協定、全面的保險範圍選項以及在需要時即時獲得後續護理。線上銷售是基因檢測市場中快速成長的部分，吸引了那些尋求在家中方便訪問的精通技術的個人。主要的直接面對消費者 (DTC) 品牌主要透過其網站和電子商務平台提供譜系和健康相關測試。線上基因檢測的優點包括易於使用（樣本採集套件直接郵寄給使用者）、週轉時間短、成本效益高以及可以進行廣泛的檢測。然而，透過線下管道提供的個人化醫療支援可能缺乏。最終，線下和線上分銷的選擇將取決於個人偏好和需求。

最終使用者：基因檢測解決方案廣泛應用於醫院和診所的疾病診斷和治療計劃。

在基因檢測中，診斷實驗室的專業服務和廣泛的檢測項目發揮著重要作用。由於對直接面對消費者 (DTC) 測試的需求不斷成長，家庭基因測試越來越受歡迎，這種測試可以深入了解血統、健康風險和個人特徵。醫院和診所是最終用戶的另一個重要組成部分，因為它們將基因檢測服務整合到疾病診斷和治療計劃的患者護理途徑中。醫院開始結合藥物基因體學學測試，根據患者的遺傳傾向定製藥物選擇。

區域洞察

美洲先進的醫療基礎設施和政府對研發的大力支持導致了基因檢測市場的蓬勃發展。然而，監管挑戰仍然存在，因為製造商必須遵守食品藥物管理局(FDA) 等機構制定的嚴格準則。歐洲的情況多種多樣，各成員國的法規也有所不同。英國脫歐為英國的法律規範帶來了不確定性。製造商和供應商必須根據每個國家的具體要求制定策略。由於人口不斷成長和慢性病患病率不斷上升，中東和非洲對於醫療保健提供者俱有巨大潛力。然而，由於醫療基礎設施有限和基因檢測服務意識較低，進入這些市場面臨挑戰。亞太地區在中國、日本和印度提供了巨大的成長機會，這些地區的大量患者需要對遺傳疾病進行準確的診斷和積極的管理。儘管存在與已開發國家類似的監管障礙，但仍有創新空間來滿足當地需求。基因檢測正在成為已開發國家個人化醫療和預防性醫療保健不可或缺的一部分，但應對複雜的法規至關重要。在新興國家，由於市場擴張的潛力，我們正在投資當地合作夥伴關係、教育計畫和基礎設施發展。最近的新聞凸顯了旨在改善基因檢測市場產品供應的合作。透過跟上區域趨勢並相應調整策略，全球基因檢測趨勢最終將為全球公共衛生成果做出重大貢獻。

FPNV定位矩陣

FPNV定位矩陣對於評估基因檢測市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對基因檢測市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.基因檢測市場規模及預測如何？

2.基因檢測市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些？

3.基因檢測市場的技術趨勢和法規結構是什麼？

4.基因檢測市場主要廠商的市場佔有率為何？

5.進入基因檢測市場合適的型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 遺傳性疾病和腫瘤疾病的盛行率以及精準醫療的需求
      • 政府的基因檢測措施和自我檢測套組的普及
    • 抑制因素
      • 對基因檢測中假陽性和假陰性的擔憂
    • 機會
      • 基因檢測技術的持續研究與新進展
      • 透過遠端醫療和數位健康平台進行基因檢測的出現
    • 任務
      • 基因檢測的後勤障礙與隱私問題
  • 市場區隔分析
    • 產品：高效資料管理和分析的軟體和服務的普及
    • 測試類型：著重於診斷特定疾病的診斷測試
    • 技術：更多地轉向 DNA定序，以實現準確的基因識別和疾病診斷
    • 應用：更多地採用基因檢測來檢測癌症的早期徵兆
    • 分銷管道：基因檢測產品投放至線上平台
    • 最終使用者：基因檢測解決方案廣泛應用於醫院和診所的疾病診斷和治療計劃。
  • 市場趨勢分析
    • 技術進步和成熟製藥公司的存在正在推動美洲基因檢測市場的成長。
    • 慢性病的增加和醫療基礎設施的擴張將支持亞太地區的基因檢測。
    • 政府措施和對個人化醫療日益成長的需求正在推動歐洲、中東和非洲地區基因檢測市場的成長。
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析

第6章 基因檢測市場：依產品

  • 耗材及設備
  • 軟體和服務

第7章按測試類型分類的基因測試市場

  • 職業測試
  • 診斷測試
  • 新生兒篩檢
  • 藥物基因組學
  • 胚胎著床前測試
  • 產前檢測
  • 症狀前和預測測試

第8章 基因檢測市場：依技術分類

  • 細胞遺傳學
  • DNA序列分析
  • 基因表現
  • 微陣列
  • PCR

第9章 基因檢測市場：依應用分類

  • 自體免疫疾病
  • 癌症
  • 慢性疾病
  • 遺傳疾病
  • 神經退化性疾病

第10章基因檢測市場：依分銷管道分類

  • 離線
  • 線上

第11章 基因檢測市場：依最終用戶分類

  • 診斷實驗室
  • 主頁設定
  • 醫院/診所

第12章 美洲基因檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第13章亞太基因檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第14章 歐洲、中東、非洲基因檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第15章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
    • DNA 公司 Asa Ren 融資 800 萬美元，更多細節公佈
    • Devyser 宣布兩種針對遺傳性癌症的新基因檢測解決方案
    • Blueprint Genetics 推出了一系列新的篩檢測試，為計劃生育和未來健康提供可行的見解。
    • Kindbody推出Kindlabs，引進內部基因檢測
    • 基因檢測 Delve 獲得 3500 萬美元創業投資資金
    • FBI核准QIAGEN 基於 NGS 的 ForenSeq MainstAY 工作流程用於美國國家 DNA 索引系統 (NDIS)
    • Sema4將以6.23億美元收購基因檢測公司GeneDx
    • Scribe 與賽諾菲擴大基因療法開發協議
    • healthOme 收購 Kailos Genetics
    • MapMyGenome 推出印度首個個人化護膚和頭髮護理 DNA 測試
    • CENTOGENE 擴大與武田的策略夥伴關係，持續為溶小體貯積症患者提供基因檢測服務
    • PathogenDx 擴大了取得專利的多重分子檢測技術的範圍，並將其引入臨床、食品和農業領域。
    • 安捷倫宣布收​​購用於癌症研究的高性能 NGS靶向序列捕獲工作流程開發商 Avida Biomed
    • Invitae 宣布與 Epic 合作簡化基因檢測
    • 綜合DNA檢測DNATEST.ID在印尼隆重推出
    • MyHeritage 發布 cMExplainer 以更準確地預測 DNA 匹配之間的家庭關係

第16章競爭組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-437E9896A512

[183 Pages Report] The Genetic Testing Market size was estimated at USD 11.89 billion in 2023 and expected to reach USD 13.55 billion in 2024, at a CAGR 14.01% to reach USD 29.79 billion by 2030.

Genetic testing comprises a diverse range of products and services to analyze an individual's DNA to identify specific genes, chromosomes, or proteins linked to inherited traits, disease predispositions, or therapeutic responses. Various sectors, including clinical diagnostics, pharmaceutical research and development, biotechnology innovation, forensics, nutrigenomics, and direct-to-consumer services, are important business sectors in this market. Several factors have contributed to the significant growth of the genetic testing market in recent years. These include advancements in DNA sequencing technologies such as next-generation sequencing (NGS), increased awareness about early diagnosis benefits through genetic testing, growing prevalence of genetic disorders, an aging population, rising demand for personalized medicine, expanding use of direct-to-consumer genetic testing services, and supportive government policies coupled with favorable reimbursement scenarios. Emerging opportunities within the genetic testing market involve integrating with other cutting-edge technologies such as artificial intelligence (AI), big data analytics, and telemedicine platforms; entering high-growth markets such as Asia-Pacific; fostering public-private partnerships to bolster genomic research initiatives; applying precision medicine programs tailored to individual genetic profiles; and using liquid biopsy technology for early cancer detection via circulating tumor DNA (ctDNA) in blood samples. Nevertheless, the growth potential is hampered by several limitations and challenges that include ethical concerns regarding privacy issues and misuse of genetic information; insufficient public awareness about genetic testing's significance; affordability constraints due to high costs of advanced tests for certain segments of the population; inconsistent guidelines and regulations across countries; concerns over false results leading to misinterpretation by healthcare professionals and patients alike; and workforce shortage in areas such as certified genetic counselors.

KEY MARKET STATISTICS
Base Year [2023] USD 11.89 billion
Estimated Year [2024] USD 13.55 billion
Forecast Year [2030] USD 29.79 billion
CAGR (%) 14.01%

Innovation and research efforts in the genetic testing market should be geared towards developing novel gene-editing technologies such as CRISPR-Cas9 for precision editing capabilities, enhancing bioinformatics tools for better interpretation of vast genomic data generated by high-throughput sequencing platforms, exploring new applications in non-invasive prenatal testing (NIPT) using cell-free fetal DNA (cffDNA); discovering unique biomarkers for disease conditions that can be targeted through pharmacogenomics approaches; and expanding into fields such as environmental genomics to assess individual responses to various environmental factors.

Product: Penetration of software and services for efficient data management and analysis

Consumables and equipment in the genetic testing industry include products including reagents, assay kits, lab instruments, and devices required for sample collection, processing, and analysis. This segment is indispensable for performing accurate and reliable tests across various applications. Diagnostic Laboratories require high-quality consumables including reagents and assay kits for accurate diagnosis of diseases. In addition, research institutes rely on advanced equipment including sequencers or PCR machines to study genetics at a molecular level. On the other hand, the software and services includes bioinformatics tools for data storage, management, and analysis, as well as genetic counseling and consulting services. Software and services emphasizes data management and analysis solutions that cater to the growing need for efficient handling of complex genomic data.

Test Type: Emphasis on diagnostic testing to perform particular disease dignosis

Carrier testing is conducted to identify individuals with one copy of a gene mutation responsible for a genetic disorder in their offspring when paired with another carrier. It is often recommended for couples planning to have children, especially when there is a family history of specific genetic conditions. On the other hand, diagnostic testing is performed after an individual develops disease symptoms or needs to confirm or rule out a particular diagnosis. Newborn screening tests help identify potentially life-threatening infections in newborns as early as possible to initiate prompt medical intervention. The tests usually involve blood samples taken shortly after birth and may also include hearing screenings and pulse oximetry tests for congenital heart defects. Pharmacogenomics studies show how an individual's genetic makeup affects their medication response. By understanding these differences, healthcare professionals can optimize drug therapy selection and dosing for improved treatment outcomes. Preimplantation genetic testing is performed on embryos created through in vitro fertilization (IVF) to identify congenital abnormalities before uterine implantation. The two primary types of preimplantation testing are preimplantation genetic diagnosis (PGD), which screens for specific genetic disorders, and preimplantation genetic screening (PGS), which assesses embryo chromosomal makeup. Prenatal testing helps detect potential health problems during pregnancy and includes diagnostic tests (e.g., amniocentesis) and screenings (e.g., non-invasive prenatal testing or NIPT). Presymptomatic and predictive testing identifies genetic mutations in asymptomatic individuals who may be at high risk for developing specific diseases later in life. This testing information allows individuals to make informed decisions about their health management strategies or take preventive measures to reduce disease risk.

Technology: Increasing shift toward DNA sequencing for precise gene identification and disease diagnosis

Cytogenetics is the study of chromosomal abnormalities and their role in genetic disorders. Cytogenetics technology involves analyzing the structure and number of chromosomes and identifying aberrations that may contribute to disease development. Common cytogenetic tests include karyotyping and fluorescence in situ hybridization (FISH). DNA sequencing technology decodes the precise order of nucleotides within DNA molecules to identify genes and determine their function. The need-based preference for this technology lies in its ability to diagnose hereditary conditions, detect genetic mutations in cancer cells, and guide personalized medicine approaches. Gene expression profiling measures the activity levels of thousands of genes simultaneously to understand their role in disease development or progression. Gene expression profiling technology is useful for identifying novel therapeutic targets, understanding treatment responses, and guiding personalized therapy decisions. Microarrays and RNA sequencing (RNA-seq) are commonly used techniques for gene expression profiling. Microarrays are high-throughput technology platforms that analyze gene expression or detect genetic variations such as single nucleotide polymorphisms (SNPs). Their need-based preference includes studying gene function at the genome level or screening for potential disease-related biomarkers. PCR is a widely utilized molecular biology technique for amplifying and quantifying specific DNA sequences. PCR has various applications, including genetic testing, pathogen detection, and forensic analysis. The need-based preference for PCR is its ability to generate results quickly and accurately with minimal sample material.

Application: Rising adoption of genetic testing to detect early signs of cancer

Autoimmune disorders result from an immune system dysfunction, leading it to attack the body's cells and tissues. Genetic testing is crucial in identifying genetic predispositions for these conditions, enabling early detection and targeted treatment plans. A comprehensive understanding of an individual's genetic makeup can help detect early signs of cancer or identify familial risks, allowing for personalized prevention strategies and targeted therapies. Heart disease, diabetes, and obesity have complex interplays between environmental factors and genetics. Genetic testing assists in determining an individual's susceptibility to these conditions and helps develop tailored lifestyle interventions or medication plans to reduce risks. Cystic fibrosis, muscular dystrophy, and thalassemia are caused by mutations in specific genes. Genetic testing enables accurate diagnosis of genetic disorders and allows carrier screening to identify at-risk couples planning to have children. Neurodegenerative diseases, including Alzheimer's, Parkinson's, and Huntington's, can have strong genetic links. Genetic testing helps uncover predispositions to these conditions, enabling preventive measures or early interventions to slow disease progression.

Distribution Channel: Deployment of genetic testing products on online platforms

Offline distribution includes traditional brick-and-mortar establishments such as hospitals, clinics, and diagnostic laboratories, catering to individuals seeking personalized guidance through face-to-face interactions with healthcare professionals. The main benefits of offline distribution are direct consultation with medical experts, secure sample collection protocols, comprehensive insurance coverage options, and immediate access to follow-up care if needed. Online distribution represents a rapidly growing segment in the genetic testing market that appeals to tech-savvy individuals seeking convenient access to services from home. Major direct-to-consumer (DTC) brands predominantly offer ancestry or health-related tests through websites or eCommerce platforms. Advantages of online genetic testing include ease of use (sample collection kits mailed directly to users), quick turnaround times, cost-effectiveness, and access to a wide range of tests. However, it may lack personalized medical support available through offline channels. Ultimately, the choice between offline and online distribution depends on individual preferences and needs.

End-User: Extensive use of genetic testing solutions in hospitals & clinics for disease diagnosis and treatment planning

Diagnostic laboratories play a pivotal role in genetic testing due to their specialized services and extensive range of tests. Home-setting genetic testing is gaining popularity owing to the growing demand for direct-to-consumer (DTC) tests that provide insights into ancestry, health risks, and personal traits. Hospitals and clinics form another essential part of the end-user landscape as they integrate genetic testing services into patient care pathways for disease diagnosis and treatment planning. Hospitals have started incorporating pharmacogenomic testing to help tailor medication selection based on the patient's genetic makeup.

Regional Insights

The advanced healthcare infrastructure and strong government support for research and development in the Americas have led to a thriving genetic testing market. However, regulatory challenges remain as manufacturers must adhere to strict guidelines set by agencies such as the Food Drug Administration (FDA). Europe presents a diverse landscape with varying regulations across its member countries. The UK's Brexit has caused uncertainty in its regulatory framework. Manufacturers or providers must tailor their strategies to each country's specific requirements. The Middle East & Africa have potential for genetic testing providers due to growing populations and the increasing prevalence of chronic diseases. However, limited healthcare infrastructure and a lack of awareness about genetic testing services create challenges for entry into these markets. The APAC region offers major growth opportunities within China, Japan, and India as their large patient populations require accurate diagnosis and proactive management of hereditary conditions. Despite regulatory hurdles similar to those in developed countries, there is room for innovation catering to local context needs. Genetic testing is becoming vital to personalized medicine and preventive healthcare in developed countries; however, navigating complex regulations is crucial. In emerging countries, where potential lies for market expansion investment in local partnerships, educational initiatives, and infrastructure development. Recent news highlights collaborations aimed at improving offerings within the genetic testing market. Global genetic testing offers numerous opportunities to stay informed about regional trends and adapt strategies accordingly, ultimately contributing meaningfully to public health outcomes worldwide.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Genetic Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Genetic Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Genetic Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Blueprint Genetics Oy, Centogene N.V., Color Health, Inc., CooperSurgical Inc., Editas Medicine, Inc., ELITechGroup SAS, Eugene Labs Pty Ltd., Eurofins Scientific SE, F. Hoffmann-La Roche AG, Fulgent Genetics, Inc., Gene by Gene, Ltd., GeneDx, LLC, Illumina, Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Living DNA Ltd., Macrogen, Inc., MyHeritage Ltd., Myriad Genetics, Inc., Natera, Inc., Newtopia Inc., PathogenDx Corporation, PerkinElmer Inc., Qiagen N.V., Sanofi S.A., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Genetic Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Consumables & Equipment
    • Software & Services
  • Test Type
    • Carrier Testing
    • Diagnostic Testing
    • New Born Screening
    • Pharmacogenomics
    • Preimplantation Testing
    • Prenatal Testing
    • Presymptomatic & Predictive Testing
  • Technology
    • Cytogenetics
    • DNA Sequencing
    • Gene Expression Profiling
    • Microarrays
    • PCR
  • Application
    • Autoimmune Disorders
    • Cancer
    • Chronic Diseases
    • Genetic Disorders
    • Neurodegenerative Diseases
  • Distribution Channel
    • Offline
    • Online
  • End-User
    • Diagnostic Laboratories
    • Home Setting
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Genetic Testing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Genetic Testing Market?

3. What are the technology trends and regulatory frameworks in the Genetic Testing Market?

4. What is the market share of the leading vendors in the Genetic Testing Market?

5. Which modes and strategic moves are suitable for entering the Genetic Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of genetic and oncology disorders and need for precision medicine
      • 5.1.1.2. Government initiatives for genetic testing and rise of self-test kits
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns associated with false positives & negatives of genetic tests
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and new developments in genetic testing technologies
      • 5.1.3.2. Emergence of genetic testing with telehealth and digital health platforms
    • 5.1.4. Challenges
      • 5.1.4.1. Logistical barriers and privacy concerns to genetic testing
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Penetration of software and services for efficient data management and analysis
    • 5.2.2. Test Type: Emphasis on diagnostic testing to perform particular disease dignosis
    • 5.2.3. Technology: Increasing shift toward DNA sequencing for precise gene identification and disease diagnosis
    • 5.2.4. Application: Rising adoption of genetic testing to detect early signs of cancer
    • 5.2.5. Distribution Channel: Deployment of genetic testing products on online platforms
    • 5.2.6. End-User: Extensive use of genetic testing solutions in hospitals & clinics for disease diagnosis and treatment planning
  • 5.3. Market Trend Analysis
    • 5.3.1. Technological advances and presence of established pharmaceutical companies enhance the genetic testing market growth in the Americas
    • 5.3.2. Increasing chronic disorders and expanding healthcare infrastructure supports genetic testing in the APAC region.
    • 5.3.3. Government initiatives and increasing demand for personalized medicine expand genetic testing market growth in the EMEA region.
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis

6. Genetic Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables & Equipment
  • 6.3. Software & Services

7. Genetic Testing Market, by Test Type

  • 7.1. Introduction
  • 7.2. Carrier Testing
  • 7.3. Diagnostic Testing
  • 7.4. New Born Screening
  • 7.5. Pharmacogenomics
  • 7.6. Preimplantation Testing
  • 7.7. Prenatal Testing
  • 7.8. Presymptomatic & Predictive Testing

8. Genetic Testing Market, by Technology

  • 8.1. Introduction
  • 8.2. Cytogenetics
  • 8.3. DNA Sequencing
  • 8.4. Gene Expression Profiling
  • 8.5. Microarrays
  • 8.6. PCR

9. Genetic Testing Market, by Application

  • 9.1. Introduction
  • 9.2. Autoimmune Disorders
  • 9.3. Cancer
  • 9.4. Chronic Diseases
  • 9.5. Genetic Disorders
  • 9.6. Neurodegenerative Diseases

10. Genetic Testing Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Offline
  • 10.3. Online

11. Genetic Testing Market, by End-User

  • 11.1. Introduction
  • 11.2. Diagnostic Laboratories
  • 11.3. Home Setting
  • 11.4. Hospitals & Clinics

12. Americas Genetic Testing Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Genetic Testing Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Genetic Testing Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. DNA company Asa Ren raises USD 8M and more briefs
    • 15.3.2. Devyser launches two new genetic testing solutions for hereditary cancer
    • 15.3.3. Blueprint Genetics introduces the new Screening Tests family; giving actionable insights for family planning, and future health
    • 15.3.4. Kindbody Brings Genetic Testing In-House with the Launch of Kindlabs
    • 15.3.5. Genetic Testing Firm Delve Gets USD 35 Million in VC Funding
    • 15.3.6. FBI approves QIAGEN's NGS-based ForenSeq MainstAY workflow for the U.S. National DNA Index System (NDIS)
    • 15.3.7. Sema4 to acquire genetic testing firm GeneDx for USD 623 Million
    • 15.3.8. Scribe and Sanofi expand genetic therapy development deal
    • 15.3.9. healthOme Acquires Kailos Genetics
    • 15.3.10. MapMyGenome launches India's First DNA Test For Personalized Skin And Hair Care
    • 15.3.11. CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
    • 15.3.12. PathogenDx Expands Reach of Its Patented Multiplexed Molecular Testing Technology, Bringing It to the Clinical, Food and Agriculture Sectors
    • 15.3.13. Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research
    • 15.3.14. Invitae Announces Partnership with Epic to Streamline Genetic Testing
    • 15.3.15. Grand Launching Of DNATEST.ID, A Comprehensive Dna Test In Indonesia
    • 15.3.16. MyHeritage Releases cM Explainer to Predict Familial Relationships Between DNA Matches with Greater Accuracy

16. Competitive Portfolio

  • 16.1. Key Company Profiles
  • 16.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. GENETIC TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. GENETIC TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GENETIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GENETIC TESTING MARKET DYNAMICS
  • FIGURE 7. GLOBAL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. GLOBAL GENETIC TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 18. GLOBAL GENETIC TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. AMERICAS GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. AMERICAS GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. UNITED STATES GENETIC TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 22. UNITED STATES GENETIC TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 27. GENETIC TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 28. GENETIC TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GENETIC TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GENETIC TESTING MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL GENETIC TESTING MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL GENETIC TESTING MARKET SIZE, BY CONSUMABLES & EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL GENETIC TESTING MARKET SIZE, BY CONSUMABLES & EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL GENETIC TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL GENETIC TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL GENETIC TESTING MARKET SIZE, BY CARRIER TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL GENETIC TESTING MARKET SIZE, BY CARRIER TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL GENETIC TESTING MARKET SIZE, BY NEW BORN SCREENING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL GENETIC TESTING MARKET SIZE, BY NEW BORN SCREENING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL GENETIC TESTING MARKET SIZE, BY PREIMPLANTATION TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL GENETIC TESTING MARKET SIZE, BY PREIMPLANTATION TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL GENETIC TESTING MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL GENETIC TESTING MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL GENETIC TESTING MARKET SIZE, BY PRESYMPTOMATIC & PREDICTIVE TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL GENETIC TESTING MARKET SIZE, BY PRESYMPTOMATIC & PREDICTIVE TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL GENETIC TESTING MARKET SIZE, BY CYTOGENETICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL GENETIC TESTING MARKET SIZE, BY CYTOGENETICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL GENETIC TESTING MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL GENETIC TESTING MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL GENETIC TESTING MARKET SIZE, BY GENE EXPRESSION PROFILING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL GENETIC TESTING MARKET SIZE, BY GENE EXPRESSION PROFILING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL GENETIC TESTING MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL GENETIC TESTING MARKET SIZE, BY MICROARRAYS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL GENETIC TESTING MARKET SIZE, BY PCR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL GENETIC TESTING MARKET SIZE, BY PCR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL GENETIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL GENETIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL GENETIC TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL GENETIC TESTING MARKET SIZE, BY CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL GENETIC TESTING MARKET SIZE, BY CHRONIC DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL GENETIC TESTING MARKET SIZE, BY CHRONIC DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL GENETIC TESTING MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL GENETIC TESTING MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL GENETIC TESTING MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL GENETIC TESTING MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL GENETIC TESTING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL GENETIC TESTING MARKET SIZE, BY OFFLINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL GENETIC TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL GENETIC TESTING MARKET SIZE, BY ONLINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL GENETIC TESTING MARKET SIZE, BY HOME SETTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL GENETIC TESTING MARKET SIZE, BY HOME SETTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL GENETIC TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL GENETIC TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 73. AMERICAS GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 74. AMERICAS GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 75. AMERICAS GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 76. AMERICAS GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 77. AMERICAS GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 78. AMERICAS GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 79. AMERICAS GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 80. AMERICAS GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 85. ARGENTINA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 86. ARGENTINA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 87. ARGENTINA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 88. ARGENTINA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 89. ARGENTINA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 90. ARGENTINA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 91. ARGENTINA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 92. ARGENTINA GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 93. BRAZIL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 94. BRAZIL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 95. BRAZIL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 96. BRAZIL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 97. BRAZIL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 98. BRAZIL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 99. BRAZIL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 100. BRAZIL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 101. BRAZIL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 102. BRAZIL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 103. BRAZIL GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 104. BRAZIL GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 105. CANADA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 106. CANADA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 107. CANADA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 108. CANADA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 109. CANADA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 110. CANADA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 111. CANADA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 112. CANADA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 113. CANADA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 114. CANADA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 115. CANADA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 116. CANADA GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 117. MEXICO GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 118. MEXICO GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 119. MEXICO GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 120. MEXICO GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 121. MEXICO GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 122. MEXICO GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 123. MEXICO GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 124. MEXICO GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 125. MEXICO GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 126. MEXICO GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 127. MEXICO GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 128. MEXICO GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 129. UNITED STATES GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 130. UNITED STATES GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 131. UNITED STATES GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 132. UNITED STATES GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 133. UNITED STATES GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 134. UNITED STATES GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 135. UNITED STATES GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. UNITED STATES GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. UNITED STATES GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 138. UNITED STATES GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 139. UNITED STATES GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 140. UNITED STATES GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 141. UNITED STATES GENETIC TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 142. UNITED STATES GENETIC TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 158. AUSTRALIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 160. AUSTRALIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 161. AUSTRALIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 162. AUSTRALIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 163. AUSTRALIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 164. AUSTRALIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 165. AUSTRALIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 166. AUSTRALIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 167. AUSTRALIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 168. AUSTRALIA GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 169. CHINA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 170. CHINA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 171. CHINA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. CHINA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. CHINA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 174. CHINA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 175. CHINA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. CHINA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. CHINA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 178. CHINA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 179. CHINA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 180. CHINA GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 181. INDIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 182. INDIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 183. INDIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. INDIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. INDIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 186. INDIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 187. INDIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. INDIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. INDIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 190. INDIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 191. INDIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 192. INDIA GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 193. INDONESIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 194. INDONESIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 195. INDONESIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. INDONESIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. INDONESIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 198. INDONESIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 199. INDONESIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 200. INDONESIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 201. INDONESIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 202. INDONESIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 203. INDONESIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 204. INDONESIA GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 205. JAPAN GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 206. JAPAN GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 207. JAPAN GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. JAPAN GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. JAPAN GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 210. JAPAN GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 211. JAPAN GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 212. JAPAN GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 213. JAPAN GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 214. JAPAN GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 215. JAPAN GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 216. JAPAN GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 217. MALAYSIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 218. MALAYSIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 219. MALAYSIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. MALAYSIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. MALAYSIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 222. MALAYSIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 223. MALAYSIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 224. MALAYSIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 225. MALAYSIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 226. MALAYSIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 227. MALAYSIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 228. MALAYSIA GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 229. PHILIPPINES GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 230. PHILIPPINES GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 231. PHILIPPINES GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. PHILIPPINES GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. PHILIPPINES GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 234. PHILIPPINES GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 235. PHILIPPINES GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 236. PHILIPPINES GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 237. PHILIPPINES GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 238. PHILIPPINES GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 239. PHILIPPINES GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 240. PHILIPPINES GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 241. SINGAPORE GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 242. SINGAPORE GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 243. SINGAPORE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. SINGAPORE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. SINGAPORE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 246. SINGAPORE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 247. SINGAPORE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 248. SINGAPORE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 249. SINGAPORE GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 250. SINGAPORE GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 251. SINGAPORE GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 252. SINGAPORE GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 255. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 256. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 257. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 258. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 259. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 260. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 261. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 262. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 263. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 264. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 265. TAIWAN GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 266. TAIWAN GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 267. TAIWAN GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. TAIWAN GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. TAIWAN GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 270. TAIWAN GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 271. TAIWAN GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 272. TAIWAN GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 273. TAIWAN GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 274. TAIWAN GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 275. TAIWAN GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 276. TAIWAN GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 277. THAILAND GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 278. THAILAND GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 279. THAILAND GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 280. THAILAND GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 281. THAILAND GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 282. THAILAND GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 283. THAILAND GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 284. THAILAND GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 285. THAILAND GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 286. THAILAND GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 287. THAILAND GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 288. THAILAND GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 289. VIETNAM GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 290. VIETNAM GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 291. VIETNAM GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 292. VIETNAM GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 293. VIETNAM GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 294. VIETNAM GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 295. VIETNAM GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 296. VIETNAM GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 297. VIETNAM GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 298. VIETNAM GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 299. VIETNAM GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 300. VIETNAM GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 309. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 310. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 311. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 312. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 313. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 314. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 315. DENMARK GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 316. DENMARK GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 317. DENMARK GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 318. DENMARK GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 319. DENMARK GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 320. DENMARK GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 321. DENMARK GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 322. DENMARK GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 323. DENMARK GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 324. DENMARK GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 325. DENMARK GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 326. DENMARK GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 327. EGYPT GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 328. EGYPT GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 329. EGYPT GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 330. EGYPT GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 331. EGYPT GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 332. EGYPT GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 333. EGYPT GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 334. EGYPT GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 335. EGYPT GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 336. EGYPT GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 337. EGYPT GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 338. EGYPT GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 339. FINLAND GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 340. FINLAND GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 341. FINLAND GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 342. FINLAND GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 343. FINLAND GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 344. FINLAND GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 345. FINLAND GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 346. FINLAND GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 347. FINLAND GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 348. FINLAND GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 349. FINLAND GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 350. FINLAND GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 351. FRANCE GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 352. FRANCE GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 353. FRANCE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 354. FRANCE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 355. FRANCE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 356. FRANCE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 357. FRANCE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 358. FRANCE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 359. FRANCE GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 360. FRANCE GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 361. FRANCE GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 362. FRANCE GENETIC TESTIN